Florida Company Recalls One Lot of Lipofit Extreme Fat Burner 2.0 After FDA Lab Finds Undeclared Fluoxetine and DNP
The voluntary nationwide recall, announced Aug. 27, 2026, covers Lot 25M12F sold online directly to consumers; the company says no adverse events have been reported to date.
One Lot, Two Hidden Pills, and No One Hurt Yet
A Florida company pulled a weight-loss product off the market on Aug. 27, 2026, after lab tests found two ingredients that weren't on the label. Ana Salazar Modela Tu Cuerpo Inc. issued a voluntary nationwide recall of Lipofit Extreme Fat Burner 2.0, covering a single batch, Lot 25M12F, that expires in September 2027[1][8]. The company sold it online, straight to individual buyers, not through any store[1].
The FDA's lab work found fluoxetine in the daytime tablets. That's the active ingredient in Prozac, a prescription antidepressant[1][3]. In the nighttime tablets, the lab found 2,4-dinitrophenol, known as DNP, an industrial chemical used in pesticides, dyes and wood preservative. The FDA has never approved DNP for any use in the human body[1].
The company's recall notice lists a long set of possible dangers tied to those two substances: irregular heartbeat, rapid heart rate, cardiac arrest, sudden death, seizures, abnormal bleeding and suicidal thoughts[1][4]. Those are risks the ingredients are known to carry, not things that have actually happened to a customer. As of the announcement, nobody had reported getting hurt from the product[1].
The Same Sentence Reads as a Win or a Failure
Here's the tension at the center of this story: the exact same fact, that FDA testing caught this before anyone was reported injured, gets read as opposite things depending on who's reading it.
To the FDA, it's proof the system worked. The agency's lab found the hidden drugs, the company pulled the lot, and the record shows zero injuries[1]. To critics of how supplements are regulated, the same sequence proves something less comfortable: testing happened only after the product was already for sale and already in people's bodies.
That gap exists because of a specific law. Under the 1994 Dietary Supplement Health and Education Act, a company can sell a supplement without getting FDA approval first[3]. The maker is responsible for its own product's safety, and the agency generally steps in only after something signals a problem, a complaint, an injury report, a lab flag. So a recall like this one isn't really a catch in the traditional sense. It's the system working in the only order the law lets it work.
Worth noting too: the FDA didn't order this recall. The company issued it, and the FDA posted the company's own notice on its recalls page[1]. That's the standard path for most supplement recalls, and it's the detail that gets flattened in a lot of the coverage that followed.
A Chemical With No Antidote
The reason DNP draws the strongest reaction isn't speculation, it's a documented track record. DNP works by disrupting how cells make energy. Normally, cells burn fuel to produce usable energy. DNP breaks that process so the body burns fuel but makes heat instead[12]. That's why it melts weight off fast, and it's also why it can push body temperature to fatal levels. There is no antidote. The dose that works and the dose that kills sit close together, which is why the FDA banned DNP for human use back in 1938[9][10][12].
Other countries treat it the same way. UK health authorities have tied DNP to 33 deaths in Britain[9]. In May 2015, Interpol sent an orange notice, essentially an international alert, about DNP to 190 countries[9]. Health Canada warns consumers directly against products containing it[9]. Published case reports describe a 21-year-old bodybuilder who died after taking 2 grams of DNP, and a 17-year-old who died after combining it with another stimulant drug called clenbuterol[10][11]. Among people who show up at poison centers worldwide after DNP exposure, roughly 12% die, according to international data collected between 2010 and 2020[9].
Fluoxetine is a different kind of risk. On its own, under a doctor's care, it's a safe and widely prescribed drug[3]. The danger here is that it was hidden. Someone taking it without knowing can't tell their doctor, so nobody checks it against other medications they take, like other antidepressants, migraine drugs or blood thinners, that can interact badly with it[1][3]. It also carries a warning about suicidal thoughts in younger users[1].
Crime, Not Category, the Industry Says
The supplement industry and allies in the Make America Healthy Again movement argue this case, while genuinely dangerous, isn't a reason to tighten rules on legitimate supplement makers. Their case: this wasn't really a supplement gone wrong. It was an illegal drug product wearing a supplement label, sold by one online seller[13][14]. Adulterating a product with hidden drugs is already a crime. The fix, in this view, is prosecuting bad actors, not adding paperwork for the much larger group of companies that don't do this.
That argument carries real weight right now because the industry has been pushing HHS Secretary Robert F. Kennedy Jr.'s department to loosen supplement rules, not tighten them, including efforts to expand what supplements can legally contain and to allow bolder health claims[13][14]. Some in that movement have separately argued that the real gap is an unpoliced import and e-commerce pipeline, not the supplement category itself.
Their incentive is straightforward: protecting and growing a large market, including a push to get supplements treated more like approved drugs for insurance and flexible-spending-account purposes[14]. A case like this one lands at an awkward moment for that push. Some supplement makers have already complained publicly that they're becoming collateral damage in a political fight rather than beneficiaries of it[13].
What the Coverage Left Out
Public-health researchers and critics of the 1994 law don't dispute the industry's facts, they dispute the framing. Calling this one bad actor, they argue, describes what happened but not why it could happen. Under current law, any supplement maker can sell first and get tested later, by design[3]. Nothing about that structure is unique to this company.
Their position carries the strongest evidence base in this story, the documented DNP death toll across multiple countries, but the weakest political footing at the moment. The administration has been moving to loosen food and supplement oversight, not add to it[15]. Tainted weight-loss products aren't new to the FDA's recall list, either. The agency has posted similar recalls before for fat burners spiked with other prescription drugs[16].
Coverage of the story split in smaller ways than in big ones. Fox Business led with the danger to consumers but left out any mention of how supplements reach the market without FDA approval in the first place. The Houston Chronicle's headline called DNP a "hidden pesticide" and credited the FDA with the warning, which is accurate about one of DNP's industrial uses but shifts attention away from the fact that the company issued the recall itself. NewsNation's headline called the product a "drug," which matches its legal classification but risks readers assuming a prescription medicine was recalled. NaturalNews called it a "ticking time bomb," a description the recall notice itself doesn't support, since no injuries had been reported.
What's Still Unknown
No source reviewed here explains how the fluoxetine and DNP actually got into the tablets, whether through the manufacturing process, the ingredient supply chain, or something else. The company hasn't offered a public explanation.
The recall reaches its buyers only as far as the company's own contact list and whatever news coverage they happen to see, since this product went straight from an online seller to individual customers with no store shelf to clear[1]. Anyone who bought Lipofit Extreme Fat Burner 2.0 from Lot 25M12F can reach the company at (954) 305-1004 for a refund or questions[1][4]. Whether more lots, or other products from other sellers, carry the same problem isn't something this recall answers on its own.
Summary
A Florida company, Ana Salazar Modela Tu Cuerpo Inc., announced a voluntary nationwide recall of its weight-loss product Lipofit Extreme Fat Burner 2.0 on Aug. 27, 2026[1][8]. FDA laboratory testing found two ingredients that were not on the label. The daytime (AM) tablets contained fluoxetine, the prescription antidepressant sold as Prozac. The nighttime (PM) tablets contained 2,4-dinitrophenol, or DNP, an industrial chemical used as a pesticide, dye and wood preservative that the FDA has not approved for any human use[1][3].
The recall covers one lot, number 25M12F, with an expiration date of 09/2027[1]. The product was sold online directly to individual consumers, not through stores[1]. The company's notice lists a long set of possible harms: irregular heartbeat, rapid heart rate, cardiac arrest and sudden death, plus seizures, abnormal bleeding and suicidal thoughts[1][4]. Those are risks the two hidden ingredients are known to carry. As of the recall notice, no one had reported being hurt by this product[1].
Everyone agrees on the lab findings. The dispute is about what the case proves. Supplement industry groups and their allies in the Make America Healthy Again movement argue this is a criminal-adulteration problem — one bad online seller spiking pills with drugs — and not a reason to tighten rules on the whole category[13][14]. Critics of current law argue the opposite: that a product only gets tested after it is already in people's bodies, and that this is exactly what the 1994 law governing supplements allows[3][14]. Both sides are pointing at the same recall.
One framing point readers should watch. The FDA did the testing and hosts the notice, but the FDA did not order this recall — the company issued it, and the agency posted it[1]. That is the normal path for most supplement recalls, and it is also the thing the two camps read in opposite directions.
The Event
On Aug. 27, 2026, Ana Salazar Modela Tu Cuerpo Inc. issued a voluntary nationwide recall of Lipofit Extreme Fat Burner 2.0, Lot 25M12F, expiration 09/2027[1][8]. The FDA said its laboratory analysis found undeclared fluoxetine in the daytime tablets and undeclared 2,4-dinitrophenol (DNP) in the nighttime tablets[1]. The product had been distributed in the United States directly to individual consumers through online sales[1]. The company told buyers to stop using it, keep it away from children and others, and not sell or give it to anyone, and listed a phone number, (954) 305-1004, for returns and questions[1][4].
Undisputed Facts
- FDA laboratory analysis found fluoxetine in the AM tablets and 2,4-dinitrophenol in the PM tablets of Lipofit Extreme Fat Burner 2.0[1].
- Neither ingredient was listed on the product label[1].
- The recall is voluntary and was issued by the company, not ordered by the FDA; the FDA published the company's press release on its recalls page[1].
- The recall covers one lot, 25M12F, expiration 09/2027, sold online directly to consumers rather than through retail stores[1][8].
- The company's notice said no adverse effects had been reported in connection with the product as of the announcement[1].
- The FDA states that DNP is not approved for any use in humans and is illegally marketed as a weight-loss product[1][3].
- Fluoxetine is the active ingredient in an FDA-approved prescription drug used for depression, bulimia and obsessive-compulsive disorder[1][3].
- The FDA describes Lipofit Extreme Fat Burner 2.0 as an unapproved new drug whose safety and effectiveness have not been established[1].
The Pressure
Strip away the moralizing and blame. What structural realities persist regardless of which narrative wins?
- Test-after-sale is the design, not a failure
- Under the 1994 supplement law, products go on sale without FDA approval and the maker vouches for its own safety. FDA usually tests only after a signal — a complaint, an injury, an import flag. So the agency's tainted-product findings will always arrive after people have already swallowed the pills[3]. This is why the same recall reads as 'the system caught it' to one side and 'the system let it happen' to the other.
- DNP kills through a mechanism with no antidote
- DNP works by uncoupling the cell's energy process: the body burns fuel but makes heat instead of usable energy. That is why it strips weight fast, and why it can drive body temperature to fatal levels. There is no reversal agent. The gap between a dose that works and a dose that kills is small, which is why FDA banned it for human use in 1938 and why UK regulators tie it to 33 deaths[9][10][12].
- Fluoxetine is dangerous mainly because it is hidden
- Fluoxetine is a safe, widely prescribed drug when a doctor manages it. Taken unknowingly, it can collide with other antidepressants, migraine drugs or blood thinners. It also carries a warning about suicidal thoughts in younger users. A buyer who does not know it is in the tablet cannot tell a doctor, so none of those checks happen[1][3].
- Online direct sales outrun any recall
- This product went straight from an online seller to individual buyers[1]. There is no store shelf to clear and no distributor list to pull. Reaching every buyer depends on the company having their contact information and on customers seeing news coverage.
Material realityThe verifiable core is narrow and solid. FDA's lab found two undeclared substances in one lot of one product sold by one Florida online seller, and that seller pulled it on Aug. 27, 2026[1][8]. No injuries had been reported at the time of the notice[1]. The harms described in the notice are possible effects of the two substances, not events that occurred. At the same time, the danger of DNP is not in dispute anywhere: it is illegal to sell for human consumption in the UK, Interpol issued an orange notice on it to 190 countries in May 2015, and Health Canada has warned against DNP products[9][17]. Tainted weight-loss products are also a recurring category for FDA, not a one-off — the agency has posted similar recalls for other fat burners spiked with prescription drugs such as sibutramine[16]. None of that changes if the political argument over supplement rules goes one way or the other.
Narrative as a weaponThree groups are shaping how this lands. The FDA and HHS benefit from the story being read as detection — testing found it, the product came off sale, nobody was hurt. Supplement industry groups and MAHA-aligned advocates want it read as crime, not category: an outlaw seller spiking pills, which would mean the answer is prosecution rather than new rules on legitimate makers, and would protect a live push to loosen supplement regulation[13][14]. Critics of the 1994 law want it read as proof of sequence: the testing happened after sale because the law permits nothing else[3][15]. Most coverage reviewed here is close to the FDA notice, so the spin shows up in small moves — calling DNP a 'pesticide' instead of an industrial chemical, calling the product a 'drug,' or dropping the fact that the company issued the recall and that no adverse events had been reported. Readers should also note the clock: the recall was announced Aug. 27, 2026, and a wave of coverage followed in early September, so items presented as breaking are describing a nearly month-old action.
How Each Side Sees It
Each major actor’s view — how it frames things, its underlying incentive, and how it’s materially affected. Tap a side to read it.
Frames it asThe agency's case is that its testing program works as designed and caught a genuinely dangerous product before anyone reported harm[1]. FDA argues that when a product sold as a supplement contains a hidden prescription drug, it stops being a supplement in the eyes of the law and becomes an unapproved new drug — which the agency can act on directly[1]. Officials also point out that the risk here is not theoretical: DNP has no approved human use at all[1][12].
WhyFDA needs to show the tainted-products program delivers results, especially while the department is also promising the supplement industry a lighter regulatory touch[13][14]. Publishing company recall notices costs the agency little and demonstrates activity.
Impact on themThe agency absorbs blame either way. If a hidden drug hurts someone, FDA is asked why it was not caught. If FDA acts aggressively, supplement allies inside its own department object[13][14].
Frames it asThe company's public position is cooperation: it announced the recall itself, told customers to stop using the product, and gave a direct phone line for returns[1][4]. A seller in this position would argue that it acted quickly on the FDA's findings and that the adulteration came from somewhere in its manufacturing or ingredient supply chain rather than from a decision to poison its own customers.
WhyLimiting legal exposure and staying out of an FDA enforcement action. A voluntary recall is the standard way a small firm avoids a seizure or injunction.
Impact on themDirect: the product is off sale, and the company is named in national coverage. The company has not publicly explained how the two substances got into the tablets, and no source reviewed here reports an explanation[1][2][3].
Frames it asTheir strongest argument is a category argument. This was not a mainstream supplement — it was an illegal drug product wearing a supplement label, sold by one online seller. Adulteration is already a crime, so the answer is enforcement against criminals, not new paperwork for lawful manufacturers. Industry groups have pressed the FDA under Health Secretary Robert F. Kennedy Jr. to widen what supplements may legally contain and to allow bolder health claims, arguing consumers deserve access to products the current system keeps out[13][14]. Some in the movement add that the real scandal is an import and e-commerce pipeline nobody polices.
WhyProtecting a large consumer market and expanding it — the goal has included getting supplements covered by insurers and flexible spending accounts, putting them closer to FDA-approved drugs in status[14].
Impact on themCases like this one cut against the deregulation push at an awkward moment. Some supplement makers have already complained they are becoming 'collateral damage' of the MAHA agenda rather than beneficiaries of it[13].
Frames it asTheir crux is timing, not villainy. Under the 1994 Dietary Supplement Health and Education Act, a supplement does not need FDA approval before it is sold. The company is responsible for its own product's safety, and the FDA generally acts only after a product is already on the market and something signals a problem[3]. So a recall like this one is not a catch — it is the system working in the only order it can work. Critics point to the medical record on DNP: UK health authorities have tied DNP to 33 deaths there, and international poison-centre data from 2010-2020 put the case-fatality rate among reported DNP exposures at roughly 12%[9]. Published case reports describe a 21-year-old bodybuilder who died after taking 2 grams of DNP, and a 17-year-old who died after taking DNP with clenbuterol[11][10].
WhyMoving the burden of proof to before sale rather than after. Many of these researchers also want more FDA inspection funding.
Impact on themThey have the strongest evidence base and the weakest position inside the current administration, which is moving toward deregulating the food and supplement programs, not tightening them[15].
Like this article?
The Bias Ledger average rating 3.8
The same story, as framed by outlets across the spectrum, ordered least to most biased. The bias score (1 = straight, 10 = heavily spun) is an AI assessment of that framing — click an outlet to see its track record. The tell is the word choice or omission that reveals the angle.
| Outlet | Vantage | Bias | How they frame it | The tell |
|---|---|---|---|---|
| The Hill | U.S. center | 2 | 'Weight loss supplement recalled over toxic substance, other undeclared ingredient' — plain and accurate. | Neutral wording, but the headline never names the company or the single lot, so the recall reads broader than the one online seller and one lot number it actually covers. |
| Nexstar Media Wire | U.S. center | 2 | 'Weight loss supplement recalled over toxic substance, other undeclared ingredient' — syndicated verbatim across dozens of local stations. | Close to a rewrite of the FDA notice, which keeps it accurate. The scale effect is the issue: one wire item becomes the story in scores of markets, so any framing choice in it is multiplied. |
| Fox Business | U.S. right | 3 | 'Nationwide recall issued for fat burner tainted with toxic chemical' — consumer-danger framing, kept in the business and products lane. | Thorough on the chemical and the symptom list, silent on the regulatory structure. No mention that supplements reach market without premarket approval, and no mention of the administration's own push to loosen supplement rules. |
| Houston Chronicle | U.S. center-left | 4 | 'FDA warns of hidden pesticide in recalled weight loss supplement' — leads with 'pesticide' and puts the FDA in the warning role. | 'Pesticide' is one of DNP's real industrial uses, but it is the most alarming of several and it implies contamination by spray residue rather than an ingredient deliberately included. Crediting FDA with the warning also blurs that the recall was the company's. |
| NewsNation | U.S. center | 4 | 'Weight loss drug recalled over toxic chemical, other undeclared drug.' | Calls the product a 'drug' in the headline. That matches FDA's legal classification of it as an unapproved new drug, but to a general reader it suggests a prescription medicine or a GLP-1 product was recalled, which is not what happened. |
| NaturalNews | U.S. alternative-health, anti-pharmaceutical | 8 | 'Ticking time bomb: Weight loss supplement recalled after toxic pesticide, hidden antidepressant found.' | 'Ticking time bomb' is a characterization no source supports — the notice reports no adverse events. The site's habitual framing also folds the hidden antidepressant into a broader anti-pharmaceutical argument, which inverts the actual finding: the drug was the contaminant, not the cure. |